Company Filing History:
Years Active: 2018-2023
Title: **Thomas Mandel Clausen: An Innovative Force in Glycan Research**
Introduction
Thomas Mandel Clausen is an accomplished inventor based in Copenhagen, Denmark. Known for his innovative contributions to the field of glycobiology, Clausen holds three patents, underscoring his expertise and dedication to advancing scientific knowledge. His work primarily focuses on the targeting of chondroitin sulfate glycans, which have significant implications for various medical conditions.
Latest Patents
One of his latest patents, titled "Targeting of chondroitin sulfate glycans," describes functional binding fragments that include the minimal binding fragments of VAR2CSA. This invention encompasses antibodies against such binding fragments of VAR2CSA and nucleic acids that encode these fragments. Additionally, the patent outlines methods for producing these fragments, along with conjugates and fusion proteins of VAR2CSA polypeptides, particularly in the context of treating conditions associated with the expression of chondroitin sulfate A (CSA). Such conditions often relate to inappropriate expression of CSA, making this research especially valuable.
Career Highlights
Thomas Mandel Clausen is associated with Var2 Pharmaceuticals Aps, a company dedicated to pioneering therapeutic solutions derived from scientific research. His work has positioned him as a significant contributor to the development of advanced medical treatments, particularly in the realm of glycan research.
Collaborations
In his endeavors, Clausen collaborates closely with esteemed colleagues, including Ali Salanti and Thor Grundtvig Theander. Together, they leverage their skills and knowledge to push the boundaries of innovation in glycobiology and create promising therapeutic avenues.
Conclusion
Through his innovative research and patents, Thomas Mandel Clausen is making a substantial difference in the field of glycobiology. His work has the potential to enhance medical treatments and improve patient outcomes, solidifying his place as a noteworthy inventor in modern science.